nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—SOD1—atherosclerosis	0.192	0.433	CbGaD
Cisplatin—GSTM1—atherosclerosis	0.121	0.274	CbGaD
Cisplatin—MPO—atherosclerosis	0.0946	0.214	CbGaD
Cisplatin—ABCC3—Ezetimibe—atherosclerosis	0.0634	0.189	CbGbCtD
Cisplatin—PTGS2—atherosclerosis	0.0355	0.08	CbGaD
Cisplatin—ABCC2—Ezetimibe—atherosclerosis	0.0288	0.0858	CbGbCtD
Cisplatin—ABCC2—Simvastatin—atherosclerosis	0.0268	0.0798	CbGbCtD
Cisplatin—ABCC2—Pravastatin—atherosclerosis	0.0262	0.0781	CbGbCtD
Cisplatin—ABCC2—Lovastatin—atherosclerosis	0.0262	0.0781	CbGbCtD
Cisplatin—ABCG2—Ezetimibe—atherosclerosis	0.026	0.0776	CbGbCtD
Cisplatin—ABCG2—Rosuvastatin—atherosclerosis	0.026	0.0776	CbGbCtD
Cisplatin—ABCG2—Pravastatin—atherosclerosis	0.0237	0.0706	CbGbCtD
Cisplatin—CYP2B6—Simvastatin—atherosclerosis	0.017	0.0507	CbGbCtD
Cisplatin—MPO—superior mesenteric artery—atherosclerosis	0.00975	0.203	CbGeAlD
Cisplatin—CYP2C9—Rosuvastatin—atherosclerosis	0.00967	0.0288	CbGbCtD
Cisplatin—ABCB1—Ezetimibe—atherosclerosis	0.00939	0.028	CbGbCtD
Cisplatin—CYP2C9—Simvastatin—atherosclerosis	0.00899	0.0268	CbGbCtD
Cisplatin—CYP2C9—Lovastatin—atherosclerosis	0.0088	0.0262	CbGbCtD
Cisplatin—CYP2C9—Pravastatin—atherosclerosis	0.0088	0.0262	CbGbCtD
Cisplatin—ABCB1—Simvastatin—atherosclerosis	0.00873	0.026	CbGbCtD
Cisplatin—ABCB1—Pravastatin—atherosclerosis	0.00854	0.0255	CbGbCtD
Cisplatin—ABCB1—Lovastatin—atherosclerosis	0.00854	0.0255	CbGbCtD
Cisplatin—Memory loss—Rosuvastatin—atherosclerosis	0.00248	0.033	CcSEcCtD
Cisplatin—Memory loss—Lovastatin—atherosclerosis	0.0021	0.028	CcSEcCtD
Cisplatin—Memory loss—Ezetimibe—atherosclerosis	0.00206	0.0275	CcSEcCtD
Cisplatin—Memory loss—Simvastatin—atherosclerosis	0.00196	0.0262	CcSEcCtD
Cisplatin—Fibrosis—Niacin—atherosclerosis	0.00185	0.0247	CcSEcCtD
Cisplatin—Memory loss—Pravastatin—atherosclerosis	0.00178	0.0237	CcSEcCtD
Cisplatin—ATP7A—endothelium—atherosclerosis	0.00164	0.0342	CbGeAlD
Cisplatin—GSTM1—artery—atherosclerosis	0.00162	0.0337	CbGeAlD
Cisplatin—ATP7A—blood vessel—atherosclerosis	0.00151	0.0315	CbGeAlD
Cisplatin—GSTM1—blood vessel—atherosclerosis	0.00126	0.0262	CbGeAlD
Cisplatin—MT1A—connective tissue—atherosclerosis	0.00108	0.0224	CbGeAlD
Cisplatin—MPO—artery—atherosclerosis	0.00104	0.0217	CbGeAlD
Cisplatin—MT2A—connective tissue—atherosclerosis	0.000896	0.0187	CbGeAlD
Cisplatin—Generalised oedema—Niacin—atherosclerosis	0.000891	0.0119	CcSEcCtD
Cisplatin—MPO—endothelium—atherosclerosis	0.00088	0.0183	CbGeAlD
Cisplatin—PTGS2—leg—atherosclerosis	0.000863	0.018	CbGeAlD
Cisplatin—MT1A—adipose tissue—atherosclerosis	0.000825	0.0172	CbGeAlD
Cisplatin—MPO—blood vessel—atherosclerosis	0.000812	0.0169	CbGeAlD
Cisplatin—MT2A—cardiovascular system—atherosclerosis	0.000779	0.0162	CbGeAlD
Cisplatin—ATP7A—connective tissue—atherosclerosis	0.000776	0.0162	CbGeAlD
Cisplatin—PTGS2—hindlimb—atherosclerosis	0.000771	0.0161	CbGeAlD
Cisplatin—GSTT1—cardiovascular system—atherosclerosis	0.000763	0.0159	CbGeAlD
Cisplatin—ATP7B—adipose tissue—atherosclerosis	0.000739	0.0154	CbGeAlD
Cisplatin—ABCC6—connective tissue—atherosclerosis	0.000712	0.0148	CbGeAlD
Cisplatin—Tenderness—Lovastatin—atherosclerosis	0.000707	0.00943	CcSEcCtD
Cisplatin—MT2A—adipose tissue—atherosclerosis	0.000687	0.0143	CbGeAlD
Cisplatin—Hepatotoxicity—Niacin—atherosclerosis	0.000686	0.00916	CcSEcCtD
Cisplatin—SLC31A2—adipose tissue—atherosclerosis	0.000676	0.0141	CbGeAlD
Cisplatin—Necrosis—Niacin—atherosclerosis	0.000675	0.00901	CcSEcCtD
Cisplatin—ATP7A—cardiovascular system—atherosclerosis	0.000675	0.0141	CbGeAlD
Cisplatin—Tenderness—Simvastatin—atherosclerosis	0.000661	0.00883	CcSEcCtD
Cisplatin—PTGS2—appendage—atherosclerosis	0.000661	0.0138	CbGeAlD
Cisplatin—GSTM1—connective tissue—atherosclerosis	0.000646	0.0135	CbGeAlD
Cisplatin—ABCC6—cardiovascular system—atherosclerosis	0.000619	0.0129	CbGeAlD
Cisplatin—Hepatocellular injury—Ezetimibe—atherosclerosis	0.000605	0.00807	CcSEcCtD
Cisplatin—Tenderness—Pravastatin—atherosclerosis	0.000598	0.00798	CcSEcCtD
Cisplatin—ATP7A—adipose tissue—atherosclerosis	0.000595	0.0124	CbGeAlD
Cisplatin—MT1A—liver—atherosclerosis	0.000579	0.0121	CbGeAlD
Cisplatin—Hepatocellular injury—Simvastatin—atherosclerosis	0.000577	0.0077	CcSEcCtD
Cisplatin—Renal failure acute—Rosuvastatin—atherosclerosis	0.000572	0.00764	CcSEcCtD
Cisplatin—Hyperuricaemia—Niacin—atherosclerosis	0.000571	0.00762	CcSEcCtD
Cisplatin—Amnesia—Rosuvastatin—atherosclerosis	0.000562	0.0075	CcSEcCtD
Cisplatin—GSTM1—cardiovascular system—atherosclerosis	0.000562	0.0117	CbGeAlD
Cisplatin—Hearing impaired—Pravastatin—atherosclerosis	0.000548	0.00731	CcSEcCtD
Cisplatin—ABCC6—adipose tissue—atherosclerosis	0.000546	0.0114	CbGeAlD
Cisplatin—Blood uric acid increased—Niacin—atherosclerosis	0.00054	0.0072	CcSEcCtD
Cisplatin—CYP4A11—liver—atherosclerosis	0.000533	0.0111	CbGeAlD
Cisplatin—Hepatocellular injury—Pravastatin—atherosclerosis	0.000522	0.00696	CcSEcCtD
Cisplatin—SOD1—adipose tissue—atherosclerosis	0.000521	0.0109	CbGeAlD
Cisplatin—ATP7B—liver—atherosclerosis	0.000519	0.0108	CbGeAlD
Cisplatin—SLC31A1—adipose tissue—atherosclerosis	0.000508	0.0106	CbGeAlD
Cisplatin—Skin exfoliation—Niacin—atherosclerosis	0.000506	0.00675	CcSEcCtD
Cisplatin—Fluid retention—Niacin—atherosclerosis	0.000503	0.00671	CcSEcCtD
Cisplatin—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000496	0.00662	CcSEcCtD
Cisplatin—GSTM1—adipose tissue—atherosclerosis	0.000495	0.0103	CbGeAlD
Cisplatin—Neuropathy—Pravastatin—atherosclerosis	0.00049	0.00654	CcSEcCtD
Cisplatin—MT2A—liver—atherosclerosis	0.000482	0.01	CbGeAlD
Cisplatin—Breast disorder—Rosuvastatin—atherosclerosis	0.000478	0.00637	CcSEcCtD
Cisplatin—Amnesia—Lovastatin—atherosclerosis	0.000477	0.00636	CcSEcCtD
Cisplatin—SLC31A2—liver—atherosclerosis	0.000474	0.00987	CbGeAlD
Cisplatin—PTGS2—artery—atherosclerosis	0.000472	0.00984	CbGeAlD
Cisplatin—GSTT1—liver—atherosclerosis	0.000472	0.00983	CbGeAlD
Cisplatin—Amnesia—Ezetimibe—atherosclerosis	0.000468	0.00624	CcSEcCtD
Cisplatin—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000464	0.00619	CcSEcCtD
Cisplatin—NQO1—connective tissue—atherosclerosis	0.000453	0.00943	CbGeAlD
Cisplatin—Pancreatitis—Rosuvastatin—atherosclerosis	0.000448	0.00597	CcSEcCtD
Cisplatin—Amnesia—Simvastatin—atherosclerosis	0.000446	0.00595	CcSEcCtD
Cisplatin—Polyuria—Niacin—atherosclerosis	0.000438	0.00584	CcSEcCtD
Cisplatin—Deafness—Pravastatin—atherosclerosis	0.000423	0.00565	CcSEcCtD
Cisplatin—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00042	0.0056	CcSEcCtD
Cisplatin—ATP7A—liver—atherosclerosis	0.000417	0.00869	CbGeAlD
Cisplatin—MPO—connective tissue—atherosclerosis	0.000416	0.00867	CbGeAlD
Cisplatin—Renal failure acute—Pravastatin—atherosclerosis	0.00041	0.00547	CcSEcCtD
Cisplatin—GSTP1—connective tissue—atherosclerosis	0.000404	0.00843	CbGeAlD
Cisplatin—Cramp muscle—Lovastatin—atherosclerosis	0.000403	0.00538	CcSEcCtD
Cisplatin—Amnesia—Pravastatin—atherosclerosis	0.000403	0.00538	CcSEcCtD
Cisplatin—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000399	0.00533	CcSEcCtD
Cisplatin—PTGS2—endothelium—atherosclerosis	0.000399	0.00831	CbGeAlD
Cisplatin—Breast disorder—Ezetimibe—atherosclerosis	0.000397	0.0053	CcSEcCtD
Cisplatin—Cramp muscle—Ezetimibe—atherosclerosis	0.000396	0.00528	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000396	0.00528	CcSEcCtD
Cisplatin—NQO1—cardiovascular system—atherosclerosis	0.000394	0.0082	CbGeAlD
Cisplatin—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000393	0.00524	CcSEcCtD
Cisplatin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000385	0.00514	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000385	0.00513	CcSEcCtD
Cisplatin—ABCC6—liver—atherosclerosis	0.000383	0.00798	CbGeAlD
Cisplatin—Pancreatitis—Lovastatin—atherosclerosis	0.00038	0.00506	CcSEcCtD
Cisplatin—Cramp muscle—Simvastatin—atherosclerosis	0.000377	0.00503	CcSEcCtD
Cisplatin—Pancreatitis—Ezetimibe—atherosclerosis	0.000372	0.00497	CcSEcCtD
Cisplatin—Face oedema—Niacin—atherosclerosis	0.000371	0.00495	CcSEcCtD
Cisplatin—ABCC5—adipose tissue—atherosclerosis	0.000371	0.00773	CbGeAlD
Cisplatin—Abdominal discomfort—Lovastatin—atherosclerosis	0.000371	0.00495	CcSEcCtD
Cisplatin—PTGS2—blood vessel—atherosclerosis	0.000368	0.00767	CbGeAlD
Cisplatin—SOD1—liver—atherosclerosis	0.000365	0.00761	CbGeAlD
Cisplatin—MPO—cardiovascular system—atherosclerosis	0.000362	0.00754	CbGeAlD
Cisplatin—SLC31A1—liver—atherosclerosis	0.000356	0.00742	CbGeAlD
Cisplatin—Pancreatitis—Simvastatin—atherosclerosis	0.000355	0.00474	CcSEcCtD
Cisplatin—GSTP1—cardiovascular system—atherosclerosis	0.000352	0.00733	CbGeAlD
Cisplatin—XDH—liver—atherosclerosis	0.000352	0.00732	CbGeAlD
Cisplatin—Orthostatic hypotension—Niacin—atherosclerosis	0.000351	0.00469	CcSEcCtD
Cisplatin—GSTM1—liver—atherosclerosis	0.000347	0.00724	CbGeAlD
Cisplatin—NQO1—adipose tissue—atherosclerosis	0.000347	0.00723	CbGeAlD
Cisplatin—Abdominal discomfort—Simvastatin—atherosclerosis	0.000347	0.00463	CcSEcCtD
Cisplatin—Cramp muscle—Pravastatin—atherosclerosis	0.000341	0.00455	CcSEcCtD
Cisplatin—Nasopharyngitis—Pravastatin—atherosclerosis	0.000339	0.00452	CcSEcCtD
Cisplatin—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000338	0.00451	CcSEcCtD
Cisplatin—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000332	0.00443	CcSEcCtD
Cisplatin—Arrhythmia—Rosuvastatin—atherosclerosis	0.000327	0.00436	CcSEcCtD
Cisplatin—Pancreatitis—Pravastatin—atherosclerosis	0.000321	0.00428	CcSEcCtD
Cisplatin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00032	0.00427	CcSEcCtD
Cisplatin—Sweating increased—Pravastatin—atherosclerosis	0.000319	0.00425	CcSEcCtD
Cisplatin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000316	0.00422	CcSEcCtD
Cisplatin—Flatulence—Rosuvastatin—atherosclerosis	0.000314	0.00418	CcSEcCtD
Cisplatin—ABCC3—adipose tissue—atherosclerosis	0.000312	0.00649	CbGeAlD
Cisplatin—GSTP1—adipose tissue—atherosclerosis	0.00031	0.00646	CbGeAlD
Cisplatin—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000299	0.00398	CcSEcCtD
Cisplatin—Stomatitis—Niacin—atherosclerosis	0.000289	0.00386	CcSEcCtD
Cisplatin—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000288	0.00384	CcSEcCtD
Cisplatin—Flushing—Lovastatin—atherosclerosis	0.000288	0.00384	CcSEcCtD
Cisplatin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000286	0.00382	CcSEcCtD
Cisplatin—Myocardial infarction—Pravastatin—atherosclerosis	0.000286	0.00382	CcSEcCtD
Cisplatin—Flushing—Ezetimibe—atherosclerosis	0.000282	0.00376	CcSEcCtD
Cisplatin—Immune system disorder—Ezetimibe—atherosclerosis	0.000274	0.00366	CcSEcCtD
Cisplatin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000274	0.00365	CcSEcCtD
Cisplatin—Alopecia—Lovastatin—atherosclerosis	0.000274	0.00365	CcSEcCtD
Cisplatin—Myalgia—Rosuvastatin—atherosclerosis	0.000271	0.00362	CcSEcCtD
Cisplatin—Flushing—Simvastatin—atherosclerosis	0.000269	0.00359	CcSEcCtD
Cisplatin—Alopecia—Ezetimibe—atherosclerosis	0.000269	0.00358	CcSEcCtD
Cisplatin—Flatulence—Lovastatin—atherosclerosis	0.000266	0.00355	CcSEcCtD
Cisplatin—Erythema—Ezetimibe—atherosclerosis	0.000265	0.00353	CcSEcCtD
Cisplatin—Malnutrition—Ezetimibe—atherosclerosis	0.000265	0.00353	CcSEcCtD
Cisplatin—Flatulence—Ezetimibe—atherosclerosis	0.000261	0.00348	CcSEcCtD
Cisplatin—ABCC5—liver—atherosclerosis	0.00026	0.00542	CbGeAlD
Cisplatin—Muscle spasms—Lovastatin—atherosclerosis	0.000259	0.00346	CcSEcCtD
Cisplatin—Infection—Rosuvastatin—atherosclerosis	0.000258	0.00344	CcSEcCtD
Cisplatin—Visual impairment—Niacin—atherosclerosis	0.000256	0.00342	CcSEcCtD
Cisplatin—Alopecia—Simvastatin—atherosclerosis	0.000256	0.00342	CcSEcCtD
Cisplatin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000255	0.0034	CcSEcCtD
Cisplatin—Muscle spasms—Ezetimibe—atherosclerosis	0.000254	0.00339	CcSEcCtD
Cisplatin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000254	0.00339	CcSEcCtD
Cisplatin—Vision blurred—Lovastatin—atherosclerosis	0.000254	0.00339	CcSEcCtD
Cisplatin—Tremor—Lovastatin—atherosclerosis	0.000253	0.00337	CcSEcCtD
Cisplatin—Visual impairment—Pravastatin—atherosclerosis	0.000252	0.00337	CcSEcCtD
Cisplatin—Erythema—Simvastatin—atherosclerosis	0.000252	0.00337	CcSEcCtD
Cisplatin—Ill-defined disorder—Lovastatin—atherosclerosis	0.00025	0.00334	CcSEcCtD
Cisplatin—Eye disorder—Niacin—atherosclerosis	0.000249	0.00332	CcSEcCtD
Cisplatin—Flatulence—Simvastatin—atherosclerosis	0.000249	0.00332	CcSEcCtD
Cisplatin—Tinnitus—Niacin—atherosclerosis	0.000248	0.00331	CcSEcCtD
Cisplatin—Flushing—Niacin—atherosclerosis	0.000247	0.0033	CcSEcCtD
Cisplatin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000245	0.00327	CcSEcCtD
Cisplatin—Anaemia—Ezetimibe—atherosclerosis	0.000245	0.00326	CcSEcCtD
Cisplatin—Tinnitus—Pravastatin—atherosclerosis	0.000244	0.00326	CcSEcCtD
Cisplatin—NQO1—liver—atherosclerosis	0.000244	0.00507	CbGeAlD
Cisplatin—Malaise—Lovastatin—atherosclerosis	0.000243	0.00325	CcSEcCtD
Cisplatin—Cardiac disorder—Pravastatin—atherosclerosis	0.000243	0.00324	CcSEcCtD
Cisplatin—Flushing—Pravastatin—atherosclerosis	0.000243	0.00324	CcSEcCtD
Cisplatin—Muscle spasms—Simvastatin—atherosclerosis	0.000243	0.00324	CcSEcCtD
Cisplatin—Leukopenia—Lovastatin—atherosclerosis	0.000241	0.00322	CcSEcCtD
Cisplatin—Malaise—Ezetimibe—atherosclerosis	0.000239	0.00318	CcSEcCtD
Cisplatin—Vision blurred—Simvastatin—atherosclerosis	0.000238	0.00317	CcSEcCtD
Cisplatin—Arrhythmia—Niacin—atherosclerosis	0.000238	0.00317	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000237	0.00316	CcSEcCtD
Cisplatin—Tremor—Simvastatin—atherosclerosis	0.000236	0.00315	CcSEcCtD
Cisplatin—Alopecia—Niacin—atherosclerosis	0.000235	0.00314	CcSEcCtD
Cisplatin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000234	0.00312	CcSEcCtD
Cisplatin—Arrhythmia—Pravastatin—atherosclerosis	0.000234	0.00312	CcSEcCtD
Cisplatin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000233	0.00311	CcSEcCtD
Cisplatin—Anaemia—Simvastatin—atherosclerosis	0.000233	0.00311	CcSEcCtD
Cisplatin—Erythema—Niacin—atherosclerosis	0.000232	0.00309	CcSEcCtD
Cisplatin—Malnutrition—Niacin—atherosclerosis	0.000232	0.00309	CcSEcCtD
Cisplatin—Alopecia—Pravastatin—atherosclerosis	0.000232	0.00309	CcSEcCtD
Cisplatin—Myalgia—Lovastatin—atherosclerosis	0.00023	0.00306	CcSEcCtD
Cisplatin—Anxiety—Lovastatin—atherosclerosis	0.000229	0.00305	CcSEcCtD
Cisplatin—Flatulence—Niacin—atherosclerosis	0.000228	0.00305	CcSEcCtD
Cisplatin—ABCB1—blood vessel—atherosclerosis	0.000228	0.00474	CbGeAlD
Cisplatin—Malaise—Simvastatin—atherosclerosis	0.000228	0.00304	CcSEcCtD
Cisplatin—Discomfort—Lovastatin—atherosclerosis	0.000227	0.00303	CcSEcCtD
Cisplatin—Leukopenia—Simvastatin—atherosclerosis	0.000226	0.00301	CcSEcCtD
Cisplatin—Myalgia—Ezetimibe—atherosclerosis	0.000225	0.003	CcSEcCtD
Cisplatin—Flatulence—Pravastatin—atherosclerosis	0.000225	0.003	CcSEcCtD
Cisplatin—MPO—liver—atherosclerosis	0.000224	0.00466	CbGeAlD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000224	0.00298	CcSEcCtD
Cisplatin—Muscle spasms—Niacin—atherosclerosis	0.000223	0.00297	CcSEcCtD
Cisplatin—Discomfort—Ezetimibe—atherosclerosis	0.000223	0.00297	CcSEcCtD
Cisplatin—Pain—Rosuvastatin—atherosclerosis	0.000222	0.00296	CcSEcCtD
Cisplatin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00022	0.00294	CcSEcCtD
Cisplatin—Muscle spasms—Pravastatin—atherosclerosis	0.000219	0.00293	CcSEcCtD
Cisplatin—Infection—Lovastatin—atherosclerosis	0.000219	0.00292	CcSEcCtD
Cisplatin—ABCC3—liver—atherosclerosis	0.000219	0.00455	CbGeAlD
Cisplatin—Vision blurred—Niacin—atherosclerosis	0.000218	0.00291	CcSEcCtD
Cisplatin—GSTP1—liver—atherosclerosis	0.000218	0.00453	CbGeAlD
Cisplatin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000216	0.00288	CcSEcCtD
Cisplatin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000216	0.00288	CcSEcCtD
Cisplatin—Vision blurred—Pravastatin—atherosclerosis	0.000215	0.00287	CcSEcCtD
Cisplatin—Myalgia—Simvastatin—atherosclerosis	0.000215	0.00287	CcSEcCtD
Cisplatin—Infection—Ezetimibe—atherosclerosis	0.000214	0.00286	CcSEcCtD
Cisplatin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000214	0.00286	CcSEcCtD
Cisplatin—Anxiety—Simvastatin—atherosclerosis	0.000214	0.00286	CcSEcCtD
Cisplatin—Tremor—Pravastatin—atherosclerosis	0.000214	0.00285	CcSEcCtD
Cisplatin—BCHE—cardiovascular system—atherosclerosis	0.000213	0.00444	CbGeAlD
Cisplatin—Discomfort—Simvastatin—atherosclerosis	0.000212	0.00283	CcSEcCtD
Cisplatin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000212	0.00282	CcSEcCtD
Cisplatin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000212	0.00282	CcSEcCtD
Cisplatin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000211	0.00282	CcSEcCtD
Cisplatin—Anaemia—Pravastatin—atherosclerosis	0.000211	0.00281	CcSEcCtD
Cisplatin—Anorexia—Lovastatin—atherosclerosis	0.00021	0.0028	CcSEcCtD
Cisplatin—Skin disorder—Ezetimibe—atherosclerosis	0.00021	0.0028	CcSEcCtD
Cisplatin—Leukopenia—Niacin—atherosclerosis	0.000207	0.00277	CcSEcCtD
Cisplatin—Oedema—Simvastatin—atherosclerosis	0.000206	0.00275	CcSEcCtD
Cisplatin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000206	0.00275	CcSEcCtD
Cisplatin—Malaise—Pravastatin—atherosclerosis	0.000206	0.00274	CcSEcCtD
Cisplatin—Infection—Simvastatin—atherosclerosis	0.000205	0.00273	CcSEcCtD
Cisplatin—Leukopenia—Pravastatin—atherosclerosis	0.000204	0.00272	CcSEcCtD
Cisplatin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000202	0.00269	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000201	0.00268	CcSEcCtD
Cisplatin—Paraesthesia—Lovastatin—atherosclerosis	0.000198	0.00264	CcSEcCtD
Cisplatin—Myalgia—Niacin—atherosclerosis	0.000197	0.00263	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000197	0.00262	CcSEcCtD
Cisplatin—Anorexia—Simvastatin—atherosclerosis	0.000196	0.00262	CcSEcCtD
Cisplatin—Dyspnoea—Lovastatin—atherosclerosis	0.000196	0.00262	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000196	0.00261	CcSEcCtD
Cisplatin—Myalgia—Pravastatin—atherosclerosis	0.000194	0.00259	CcSEcCtD
Cisplatin—Paraesthesia—Ezetimibe—atherosclerosis	0.000194	0.00259	CcSEcCtD
Cisplatin—Anxiety—Pravastatin—atherosclerosis	0.000194	0.00258	CcSEcCtD
Cisplatin—Dyspnoea—Ezetimibe—atherosclerosis	0.000192	0.00257	CcSEcCtD
Cisplatin—Discomfort—Pravastatin—atherosclerosis	0.000192	0.00256	CcSEcCtD
Cisplatin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000191	0.00255	CcSEcCtD
Cisplatin—Decreased appetite—Lovastatin—atherosclerosis	0.000191	0.00255	CcSEcCtD
Cisplatin—CYP2B6—cardiovascular system—atherosclerosis	0.00019	0.00396	CbGeAlD
Cisplatin—Oedema—Niacin—atherosclerosis	0.000189	0.00252	CcSEcCtD
Cisplatin—Anaphylactic shock—Niacin—atherosclerosis	0.000189	0.00252	CcSEcCtD
Cisplatin—PTGS2—connective tissue—atherosclerosis	0.000189	0.00393	CbGeAlD
Cisplatin—Pain—Lovastatin—atherosclerosis	0.000188	0.00251	CcSEcCtD
Cisplatin—CYP2C9—cardiovascular system—atherosclerosis	0.000188	0.00392	CbGeAlD
Cisplatin—BCHE—adipose tissue—atherosclerosis	0.000188	0.00391	CbGeAlD
Cisplatin—Decreased appetite—Ezetimibe—atherosclerosis	0.000188	0.0025	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000188	0.0025	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000186	0.00249	CcSEcCtD
Cisplatin—Asthenia—Rosuvastatin—atherosclerosis	0.000186	0.00249	CcSEcCtD
Cisplatin—Oedema—Pravastatin—atherosclerosis	0.000186	0.00248	CcSEcCtD
Cisplatin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000186	0.00248	CcSEcCtD
Cisplatin—Infection—Pravastatin—atherosclerosis	0.000185	0.00247	CcSEcCtD
Cisplatin—Paraesthesia—Simvastatin—atherosclerosis	0.000185	0.00247	CcSEcCtD
Cisplatin—Pain—Ezetimibe—atherosclerosis	0.000185	0.00246	CcSEcCtD
Cisplatin—Tachycardia—Niacin—atherosclerosis	0.000185	0.00246	CcSEcCtD
Cisplatin—Skin disorder—Niacin—atherosclerosis	0.000184	0.00245	CcSEcCtD
Cisplatin—Dyspnoea—Simvastatin—atherosclerosis	0.000184	0.00245	CcSEcCtD
Cisplatin—Hyperhidrosis—Niacin—atherosclerosis	0.000183	0.00244	CcSEcCtD
Cisplatin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000182	0.00243	CcSEcCtD
Cisplatin—ABCG2—adipose tissue—atherosclerosis	0.000182	0.00378	CbGeAlD
Cisplatin—Feeling abnormal—Lovastatin—atherosclerosis	0.000181	0.00242	CcSEcCtD
Cisplatin—Anorexia—Niacin—atherosclerosis	0.00018	0.0024	CcSEcCtD
Cisplatin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00018	0.0024	CcSEcCtD
Cisplatin—Decreased appetite—Simvastatin—atherosclerosis	0.000179	0.00239	CcSEcCtD
Cisplatin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000178	0.00237	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000178	0.00237	CcSEcCtD
Cisplatin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000178	0.00237	CcSEcCtD
Cisplatin—Anorexia—Pravastatin—atherosclerosis	0.000177	0.00237	CcSEcCtD
Cisplatin—Hypotension—Niacin—atherosclerosis	0.000177	0.00236	CcSEcCtD
Cisplatin—Pain—Simvastatin—atherosclerosis	0.000176	0.00235	CcSEcCtD
Cisplatin—ABCC2—liver—atherosclerosis	0.000175	0.00364	CbGeAlD
Cisplatin—Body temperature increased—Lovastatin—atherosclerosis	0.000174	0.00232	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000172	0.0023	CcSEcCtD
Cisplatin—Body temperature increased—Ezetimibe—atherosclerosis	0.000171	0.00228	CcSEcCtD
Cisplatin—Paraesthesia—Niacin—atherosclerosis	0.00017	0.00226	CcSEcCtD
Cisplatin—Feeling abnormal—Simvastatin—atherosclerosis	0.00017	0.00226	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00017	0.00226	CcSEcCtD
Cisplatin—Dyspnoea—Niacin—atherosclerosis	0.000169	0.00225	CcSEcCtD
Cisplatin—Paraesthesia—Pravastatin—atherosclerosis	0.000167	0.00223	CcSEcCtD
Cisplatin—Dyspnoea—Pravastatin—atherosclerosis	0.000166	0.00221	CcSEcCtD
Cisplatin—Decreased appetite—Niacin—atherosclerosis	0.000164	0.00219	CcSEcCtD
Cisplatin—PTGS2—cardiovascular system—atherosclerosis	0.000164	0.00342	CbGeAlD
Cisplatin—Rash—Rosuvastatin—atherosclerosis	0.000164	0.00219	CcSEcCtD
Cisplatin—Dermatitis—Rosuvastatin—atherosclerosis	0.000164	0.00218	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000163	0.00218	CcSEcCtD
Cisplatin—Body temperature increased—Simvastatin—atherosclerosis	0.000163	0.00217	CcSEcCtD
Cisplatin—Hypersensitivity—Lovastatin—atherosclerosis	0.000162	0.00216	CcSEcCtD
Cisplatin—Decreased appetite—Pravastatin—atherosclerosis	0.000162	0.00216	CcSEcCtD
Cisplatin—Pain—Niacin—atherosclerosis	0.000162	0.00216	CcSEcCtD
Cisplatin—Pain—Pravastatin—atherosclerosis	0.000159	0.00212	CcSEcCtD
Cisplatin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000159	0.00212	CcSEcCtD
Cisplatin—Asthenia—Lovastatin—atherosclerosis	0.000158	0.00211	CcSEcCtD
Cisplatin—Asthenia—Ezetimibe—atherosclerosis	0.000155	0.00207	CcSEcCtD
Cisplatin—Nausea—Rosuvastatin—atherosclerosis	0.000154	0.00206	CcSEcCtD
Cisplatin—Feeling abnormal—Pravastatin—atherosclerosis	0.000153	0.00205	CcSEcCtD
Cisplatin—Hypersensitivity—Simvastatin—atherosclerosis	0.000152	0.00202	CcSEcCtD
Cisplatin—Diarrhoea—Lovastatin—atherosclerosis	0.000151	0.00201	CcSEcCtD
Cisplatin—Body temperature increased—Niacin—atherosclerosis	0.000149	0.00199	CcSEcCtD
Cisplatin—Asthenia—Simvastatin—atherosclerosis	0.000148	0.00197	CcSEcCtD
Cisplatin—Diarrhoea—Ezetimibe—atherosclerosis	0.000148	0.00197	CcSEcCtD
Cisplatin—Body temperature increased—Pravastatin—atherosclerosis	0.000147	0.00196	CcSEcCtD
Cisplatin—PTGS2—adipose tissue—atherosclerosis	0.000145	0.00302	CbGeAlD
Cisplatin—Diarrhoea—Simvastatin—atherosclerosis	0.000141	0.00188	CcSEcCtD
Cisplatin—Vomiting—Lovastatin—atherosclerosis	0.00014	0.00187	CcSEcCtD
Cisplatin—Hypersensitivity—Niacin—atherosclerosis	0.000139	0.00186	CcSEcCtD
Cisplatin—Rash—Lovastatin—atherosclerosis	0.000139	0.00185	CcSEcCtD
Cisplatin—Dermatitis—Lovastatin—atherosclerosis	0.000139	0.00185	CcSEcCtD
Cisplatin—Vomiting—Ezetimibe—atherosclerosis	0.000137	0.00183	CcSEcCtD
Cisplatin—Hypersensitivity—Pravastatin—atherosclerosis	0.000137	0.00183	CcSEcCtD
Cisplatin—Rash—Ezetimibe—atherosclerosis	0.000136	0.00182	CcSEcCtD
Cisplatin—Dermatitis—Ezetimibe—atherosclerosis	0.000136	0.00181	CcSEcCtD
Cisplatin—Asthenia—Niacin—atherosclerosis	0.000136	0.00181	CcSEcCtD
Cisplatin—Asthenia—Pravastatin—atherosclerosis	0.000134	0.00178	CcSEcCtD
Cisplatin—BCHE—liver—atherosclerosis	0.000132	0.00274	CbGeAlD
Cisplatin—Vomiting—Simvastatin—atherosclerosis	0.000131	0.00175	CcSEcCtD
Cisplatin—Nausea—Lovastatin—atherosclerosis	0.000131	0.00174	CcSEcCtD
Cisplatin—Rash—Simvastatin—atherosclerosis	0.00013	0.00173	CcSEcCtD
Cisplatin—Dermatitis—Simvastatin—atherosclerosis	0.00013	0.00173	CcSEcCtD
Cisplatin—Diarrhoea—Niacin—atherosclerosis	0.000129	0.00173	CcSEcCtD
Cisplatin—Nausea—Ezetimibe—atherosclerosis	0.000128	0.00171	CcSEcCtD
Cisplatin—ABCG2—liver—atherosclerosis	0.000127	0.00265	CbGeAlD
Cisplatin—Diarrhoea—Pravastatin—atherosclerosis	0.000127	0.0017	CcSEcCtD
Cisplatin—Nausea—Simvastatin—atherosclerosis	0.000122	0.00163	CcSEcCtD
Cisplatin—Vomiting—Niacin—atherosclerosis	0.00012	0.0016	CcSEcCtD
Cisplatin—Rash—Niacin—atherosclerosis	0.000119	0.00159	CcSEcCtD
Cisplatin—Dermatitis—Niacin—atherosclerosis	0.000119	0.00159	CcSEcCtD
Cisplatin—Vomiting—Pravastatin—atherosclerosis	0.000118	0.00158	CcSEcCtD
Cisplatin—CYP2B6—liver—atherosclerosis	0.000118	0.00245	CbGeAlD
Cisplatin—Rash—Pravastatin—atherosclerosis	0.000117	0.00157	CcSEcCtD
Cisplatin—Dermatitis—Pravastatin—atherosclerosis	0.000117	0.00156	CcSEcCtD
Cisplatin—CYP2C9—liver—atherosclerosis	0.000116	0.00242	CbGeAlD
Cisplatin—Nausea—Niacin—atherosclerosis	0.000112	0.0015	CcSEcCtD
Cisplatin—Nausea—Pravastatin—atherosclerosis	0.000111	0.00148	CcSEcCtD
Cisplatin—ABCB1—cardiovascular system—atherosclerosis	0.000102	0.00212	CbGeAlD
Cisplatin—PTGS2—liver—atherosclerosis	0.000102	0.00211	CbGeAlD
Cisplatin—ABCB1—adipose tissue—atherosclerosis	8.96e-05	0.00187	CbGeAlD
Cisplatin—ABCB1—liver—atherosclerosis	6.28e-05	0.00131	CbGeAlD
Cisplatin—PTGS2—Metabolism—LDLR—atherosclerosis	4.04e-06	4.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP27A1—atherosclerosis	4.03e-06	4.1e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—INS—atherosclerosis	3.99e-06	4.06e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOE—atherosclerosis	3.98e-06	4.04e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HMOX1—atherosclerosis	3.96e-06	4.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.95e-06	4.02e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NAMPT—atherosclerosis	3.95e-06	4.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.95e-06	4.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CETP—atherosclerosis	3.94e-06	4.01e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CAV1—atherosclerosis	3.94e-06	4e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOA1—atherosclerosis	3.93e-06	3.99e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LIPC—atherosclerosis	3.93e-06	3.99e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	3.92e-06	3.98e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOC3—atherosclerosis	3.9e-06	3.97e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.88e-06	3.95e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LDLR—atherosclerosis	3.88e-06	3.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.87e-06	3.93e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—atherosclerosis	3.85e-06	3.92e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.82e-06	3.89e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOA2—atherosclerosis	3.82e-06	3.89e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.82e-06	3.89e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALOX15—atherosclerosis	3.82e-06	3.89e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOB—atherosclerosis	3.8e-06	3.86e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CETP—atherosclerosis	3.79e-06	3.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SCARB1—atherosclerosis	3.78e-06	3.84e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ABCG5—atherosclerosis	3.78e-06	3.84e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP27A1—atherosclerosis	3.77e-06	3.83e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.71e-06	3.77e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—atherosclerosis	3.7e-06	3.76e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—atherosclerosis	3.69e-06	3.75e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.69e-06	3.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.68e-06	3.74e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—atherosclerosis	3.66e-06	3.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LPA—atherosclerosis	3.65e-06	3.71e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SCARB1—atherosclerosis	3.63e-06	3.69e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—LPL—atherosclerosis	3.62e-06	3.68e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.62e-06	3.68e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CG—atherosclerosis	3.59e-06	3.65e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HMOX1—atherosclerosis	3.58e-06	3.63e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	3.57e-06	3.63e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOA2—atherosclerosis	3.57e-06	3.63e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	3.57e-06	3.63e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALOX15—atherosclerosis	3.57e-06	3.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMGCR—atherosclerosis	3.57e-06	3.62e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HMOX1—atherosclerosis	3.54e-06	3.6e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPX1—atherosclerosis	3.54e-06	3.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BGN—atherosclerosis	3.53e-06	3.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCG5—atherosclerosis	3.53e-06	3.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.52e-06	3.58e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NOS3—atherosclerosis	3.5e-06	3.56e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOA5—atherosclerosis	3.5e-06	3.55e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—atherosclerosis	3.46e-06	3.52e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CD36—atherosclerosis	3.44e-06	3.5e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—atherosclerosis	3.44e-06	3.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMGCR—atherosclerosis	3.43e-06	3.48e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOB—atherosclerosis	3.43e-06	3.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LPA—atherosclerosis	3.41e-06	3.46e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—INS—atherosclerosis	3.4e-06	3.45e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOB—atherosclerosis	3.39e-06	3.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.37e-06	3.42e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.33e-06	3.39e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—atherosclerosis	3.33e-06	3.39e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BGN—atherosclerosis	3.3e-06	3.35e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—atherosclerosis	3.3e-06	3.35e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—atherosclerosis	3.29e-06	3.34e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.28e-06	3.33e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—LPL—atherosclerosis	3.27e-06	3.32e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOA5—atherosclerosis	3.27e-06	3.32e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—atherosclerosis	3.26e-06	3.32e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALOX5—atherosclerosis	3.25e-06	3.3e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—LPL—atherosclerosis	3.24e-06	3.29e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—atherosclerosis	3.2e-06	3.26e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARA—atherosclerosis	3.2e-06	3.25e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPX1—atherosclerosis	3.19e-06	3.24e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—atherosclerosis	3.19e-06	3.24e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCA1—atherosclerosis	3.18e-06	3.23e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.17e-06	3.22e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPX1—atherosclerosis	3.16e-06	3.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.14e-06	3.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.13e-06	3.18e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOB—atherosclerosis	3.12e-06	3.17e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—atherosclerosis	3.11e-06	3.16e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.11e-06	3.16e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CD36—atherosclerosis	3.11e-06	3.16e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AGT—atherosclerosis	3.1e-06	3.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.08e-06	3.13e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CD36—atherosclerosis	3.08e-06	3.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.07e-06	3.12e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCA1—atherosclerosis	3.06e-06	3.1e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOE—atherosclerosis	3.04e-06	3.09e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.04e-06	3.09e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CAV1—atherosclerosis	3.01e-06	3.06e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOA1—atherosclerosis	3e-06	3.05e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NOS3—atherosclerosis	2.98e-06	3.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—LPL—atherosclerosis	2.98e-06	3.03e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—atherosclerosis	2.94e-06	2.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NAMPT—atherosclerosis	2.92e-06	2.96e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—atherosclerosis	2.91e-06	2.96e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LIPC—atherosclerosis	2.9e-06	2.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRKCG—atherosclerosis	2.9e-06	2.94e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARA—atherosclerosis	2.89e-06	2.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOC3—atherosclerosis	2.88e-06	2.93e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LDLR—atherosclerosis	2.86e-06	2.91e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARA—atherosclerosis	2.86e-06	2.91e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.81e-06	2.85e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AGT—atherosclerosis	2.8e-06	2.84e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CETP—atherosclerosis	2.8e-06	2.84e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AGT—atherosclerosis	2.77e-06	2.81e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.74e-06	2.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—atherosclerosis	2.74e-06	2.79e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOE—atherosclerosis	2.74e-06	2.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMOX1—atherosclerosis	2.73e-06	2.77e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—atherosclerosis	2.72e-06	2.77e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.72e-06	2.77e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAV1—atherosclerosis	2.72e-06	2.76e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOE—atherosclerosis	2.71e-06	2.76e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOA1—atherosclerosis	2.71e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.71e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LIPC—atherosclerosis	2.71e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOC3—atherosclerosis	2.69e-06	2.73e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAV1—atherosclerosis	2.69e-06	2.73e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOA1—atherosclerosis	2.68e-06	2.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—atherosclerosis	2.68e-06	2.73e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SCARB1—atherosclerosis	2.68e-06	2.72e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LDLR—atherosclerosis	2.67e-06	2.72e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—atherosclerosis	2.65e-06	2.69e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMOX1—atherosclerosis	2.62e-06	2.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOB—atherosclerosis	2.61e-06	2.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CETP—atherosclerosis	2.61e-06	2.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFB—atherosclerosis	2.61e-06	2.65e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—atherosclerosis	2.61e-06	2.65e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—INS—atherosclerosis	2.59e-06	2.64e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—atherosclerosis	2.54e-06	2.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMGCR—atherosclerosis	2.53e-06	2.57e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOB—atherosclerosis	2.51e-06	2.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.5e-06	2.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOE—atherosclerosis	2.5e-06	2.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—LPL—atherosclerosis	2.49e-06	2.53e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.48e-06	2.52e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—atherosclerosis	2.47e-06	2.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CAV1—atherosclerosis	2.47e-06	2.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOA1—atherosclerosis	2.47e-06	2.51e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—atherosclerosis	2.45e-06	2.49e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—atherosclerosis	2.44e-06	2.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.43e-06	2.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX1—atherosclerosis	2.43e-06	2.47e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—atherosclerosis	2.4e-06	2.44e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LPL—atherosclerosis	2.4e-06	2.44e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—atherosclerosis	2.39e-06	2.43e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—atherosclerosis	2.38e-06	2.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CD36—atherosclerosis	2.37e-06	2.41e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—atherosclerosis	2.36e-06	2.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.36e-06	2.4e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—INS—atherosclerosis	2.34e-06	2.38e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX1—atherosclerosis	2.34e-06	2.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—atherosclerosis	2.33e-06	2.36e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—INS—atherosclerosis	2.32e-06	2.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CD36—atherosclerosis	2.28e-06	2.31e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—atherosclerosis	2.28e-06	2.31e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ABCA1—atherosclerosis	2.25e-06	2.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—atherosclerosis	2.25e-06	2.28e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—atherosclerosis	2.22e-06	2.25e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—atherosclerosis	2.22e-06	2.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARA—atherosclerosis	2.2e-06	2.24e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—atherosclerosis	2.16e-06	2.19e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—atherosclerosis	2.16e-06	2.19e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—atherosclerosis	2.15e-06	2.18e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AGT—atherosclerosis	2.13e-06	2.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—INS—atherosclerosis	2.13e-06	2.17e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.13e-06	2.16e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—atherosclerosis	2.12e-06	2.16e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARA—atherosclerosis	2.12e-06	2.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.1e-06	2.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOE—atherosclerosis	2.09e-06	2.12e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—atherosclerosis	2.08e-06	2.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAV1—atherosclerosis	2.07e-06	2.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOA1—atherosclerosis	2.07e-06	2.1e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—atherosclerosis	2.05e-06	2.09e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AGT—atherosclerosis	2.05e-06	2.08e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—atherosclerosis	2.03e-06	2.07e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOE—atherosclerosis	2.01e-06	2.04e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAV1—atherosclerosis	1.99e-06	2.02e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOA1—atherosclerosis	1.99e-06	2.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—atherosclerosis	1.96e-06	1.99e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—atherosclerosis	1.94e-06	1.97e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMOX1—atherosclerosis	1.93e-06	1.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.89e-06	1.92e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—atherosclerosis	1.88e-06	1.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—atherosclerosis	1.87e-06	1.9e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.86e-06	1.89e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—atherosclerosis	1.86e-06	1.89e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOB—atherosclerosis	1.85e-06	1.88e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—atherosclerosis	1.82e-06	1.85e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.81e-06	1.84e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.81e-06	1.84e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—atherosclerosis	1.8e-06	1.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—INS—atherosclerosis	1.79e-06	1.82e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LPL—atherosclerosis	1.77e-06	1.8e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—atherosclerosis	1.75e-06	1.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOB—atherosclerosis	1.73e-06	1.76e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX1—atherosclerosis	1.73e-06	1.75e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—INS—atherosclerosis	1.72e-06	1.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.68e-06	1.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CD36—atherosclerosis	1.68e-06	1.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LPL—atherosclerosis	1.65e-06	1.68e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—atherosclerosis	1.64e-06	1.66e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX1—atherosclerosis	1.61e-06	1.64e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—atherosclerosis	1.61e-06	1.64e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—atherosclerosis	1.59e-06	1.62e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—atherosclerosis	1.57e-06	1.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CD36—atherosclerosis	1.57e-06	1.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—atherosclerosis	1.57e-06	1.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARA—atherosclerosis	1.56e-06	1.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AGT—atherosclerosis	1.51e-06	1.54e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—atherosclerosis	1.51e-06	1.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.49e-06	1.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOE—atherosclerosis	1.48e-06	1.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAV1—atherosclerosis	1.47e-06	1.49e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOA1—atherosclerosis	1.47e-06	1.49e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARA—atherosclerosis	1.46e-06	1.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AGT—atherosclerosis	1.41e-06	1.44e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOE—atherosclerosis	1.38e-06	1.41e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.38e-06	1.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAV1—atherosclerosis	1.37e-06	1.39e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—atherosclerosis	1.37e-06	1.39e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOA1—atherosclerosis	1.37e-06	1.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.34e-06	1.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—atherosclerosis	1.33e-06	1.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—atherosclerosis	1.29e-06	1.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—atherosclerosis	1.27e-06	1.3e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—INS—atherosclerosis	1.27e-06	1.29e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.25e-06	1.27e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—atherosclerosis	1.24e-06	1.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—atherosclerosis	1.21e-06	1.23e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—INS—atherosclerosis	1.18e-06	1.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—atherosclerosis	1.16e-06	1.18e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—atherosclerosis	1.11e-06	1.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—atherosclerosis	1.08e-06	1.1e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—atherosclerosis	1.05e-06	1.06e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—atherosclerosis	1.04e-06	1.05e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—atherosclerosis	1.02e-06	1.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—atherosclerosis	9.49e-07	9.64e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—atherosclerosis	9.44e-07	9.59e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—atherosclerosis	9.34e-07	9.49e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—atherosclerosis	9.32e-07	9.47e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—atherosclerosis	8.6e-07	8.74e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—atherosclerosis	7.2e-07	7.32e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—atherosclerosis	6.92e-07	7.03e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—atherosclerosis	5.1e-07	5.19e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—atherosclerosis	4.77e-07	4.85e-06	CbGpPWpGaD
